Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part II diagnosis and management
Drug-induced hypersensitivity syndrome, also known as drug reaction with eosinophilia and systemic symptoms, is a severe cutaneous adverse reaction characterized by an exanthem, fever, and hematologic and visceral organ involvement. The differential diagnosis includes other cutaneous adverse reactions, infections, inflammatory and autoimmune diseases, and neoplastic disorders. Three sets of diagnostic criteria have been proposed; however, consensus is lacking. The cornerstone of management is immediate discontinuation of the suspected drug culprit.
Source: Journal of the American Academy of Dermatology - Category: Dermatology Authors: Brian M. Wei, Lindy P. Fox, Benjamin H. Kaffenberger, Abraham M. Korman, Robert G. Micheletti, Arash Mostaghimi, Megan H. Noe, Misha Rosenbach, Kanade Shinkai, Jason H. Kwah, Elizabeth J. Phillips, Jean L. Bolognia, William Damsky, Caroline A. Nelson Tags: Continuing medical education Source Type: research
More News: Academies | Autoimmune Disease | Continuing Medical Education | Dermatology | Drugs & Pharmacology | Education | Hematology | Skin | Universities & Medical Training